Tracy A. Brooks

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery”.

Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery

AAPS PharmSciTech(2022)10.1208/s12249-022-02294-w

N/A

0DataRank · unranked

62 citations

Utkarsh J. Dang, Yuhao Yuan, Alexandra Maria Psaras, Ositomiwa O. Osipitan, Tracy A. Brooks +3 more

Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates

Molecular Pharmaceutics(2022)10.1021/acs.molpharmaceut.2c00392

N/A

0DataRank · unranked

44 citations

Brittany M. Brems, Emmanuel O. Olawode, Jared T. Miller, Tracy A. Brooks, L. Nathan Tumey +1 more

A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin-cleavable ADC linkers

Xenobiotica(2024)10.1080/00498254.2024.2352051

N/A

0DataRank · unranked

10 citations

Karina M. Zielinski, Fanny Xu, Kayla K. Elder, Steven J. McKay, Victor T. Ojo +5 more

Nonglycosylated, Legumain-Cleavable ISACs Drive Potent Antitumor Immunotherapy via a Bystander Effect

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-1153

N/A

0DataRank · unranked

0 citations

Mohan Reddy Mullapudi, Lina Wu, Michele Yi, Mohammad Asikur Rahman, Aiman A. Yaseen +4 more